Wu, J., Bryla, C., McCoy, A., Lisa, B., Garren, N., Siegel, C., . . . Gilbert, M. R. (2017). ACTR-69. PHASE I TRIAL OF TG02 PLUS DOSE-DENSE OR METRONOMIC TEMOZOLOMIDE FOR ADULTS WITH RECURRENT ANAPLASTIC ASTROCYTOMA AND GLIOBLASTOMA. Neuro Oncol.
Citación estilo ChicagoWu, Jing, et al. "ACTR-69. PHASE I TRIAL OF TG02 PLUS DOSE-DENSE OR METRONOMIC TEMOZOLOMIDE FOR ADULTS WITH RECURRENT ANAPLASTIC ASTROCYTOMA AND GLIOBLASTOMA." Neuro Oncol 2017.
Cita MLAWu, Jing, et al. "ACTR-69. PHASE I TRIAL OF TG02 PLUS DOSE-DENSE OR METRONOMIC TEMOZOLOMIDE FOR ADULTS WITH RECURRENT ANAPLASTIC ASTROCYTOMA AND GLIOBLASTOMA." Neuro Oncol 2017.
Precaución: Estas citas no son 100% exactas.